| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8790667 | American Journal of Ophthalmology | 2018 | 41 Pages |
Abstract
FABP4 shows potential as a novel biomarker for DR prediction in Chinese patients with T2DM, and strict glycemic control and more frequent retinal examination should be highlighted for T2DM patients with the highest quartile range of FABP4.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Xian-zhao Zhang, Wen-Jun Tu, Hong Wang, Qi Zhao, Qiang Liu, Lei Sun, Lei Yu,